Marcos Rogério de Lima — Medical & Compliance Record
Medical and compliance record for Marcos Rogério de Lima: 2 anti-doping sanctions, 1 post-fight medical suspension, 1 injury record, 10 anti-doping testing entries. Every entry is dated and linked to its source.
This page reproduces publicly reported regulatory and medical-administrative records. Every entry names the body that issued it. Anti-doping testing entries are counts of publicly reported test sessions and are not pass/fail results — a test session is not a positive test. Records are reproduced as published and are not medical advice.
2Anti-doping sanctions
1Medical suspensions
1Injury records
10Testing entries
Anti-doping sanction (2)
Anti-doping suspension / ineligibility
Anti-doping sanction
De Lima tested positive for the presence of Anastrozole, a prohibited at all times substance in the class of Hormone and Metabolic Modulators on the UFC Prohibited List from an out of competition sample collected from him on January 13, 2025. De Lima submitted extensive medical documentation confirming a medical condition which necessitated the prescribed treatment of anastrozole. Anastrozole was clearly listed on the label’s listed ingredient of the prescribed, compounded substance that he consumed. However, De Lima neither checked on the prohibited status himself of the prescription before using it, nor contacted anyone within the UFC Anti-Doping Compliance Team for help to check the status of the prescription. Additionally, this is De Lima’s second violation under the UFC ADP, the first arising from a contaminated supplement he received and consumed from a compounding pharmacy in Brazil in 2017. Of importance in this case, his 2017 violation was also for the presence of Anastrozole in his system.
Date
6 March 2025
Status
Suspended / sanctioned
Suspension length
1 year
Period start
10 November 2024
Period end
10 November 2025
Issuing body
Combat Sports Anti-Doping (CSAD)
Issued by: Combat Sports Anti-Doping (CSAD)
Official drug finding
Anti-doping sanction
USADA announced today that it has confirmed two compounding pharmacies in Brazil produced and sold contaminated supplements that led to the positive tests of three athletes subject to the UFC ® Anti-Doping Policy.
Date
23 April 2018
Status
Positive finding / resolved case
Substance
hydrochlorothiazide, and Marcos Rogerio de Lima, who tested positive for hydrochlorothiazide and anastrozole
Issuing body
U.S. Anti-Doping Agency (USADA)
Issued by: U.S. Anti-Doping Agency (USADA)
Post-fight medical suspension (1)
Routine commission clearance requirements issued after a bout. These imply no wrongdoing.
Post-fight medical suspension
Post-fight medical suspension
The commission recorded 180/180 days; 45/30 days; physician clearance required for possible fracture: right foot.